Literature DB >> 30444990

Management of Patients With Coronary Artery Malperfusion Secondary to Type A Aortic Dissection.

Maximilian Kreibich1, Joseph E Bavaria2, Emanuela Branchetti2, Chase R Brown2, Zehang Chen2, Fabliha Khurshan2, Mary Siki2, Prashanth Vallabhajosyula2, Wilson Y Szeto2, Nimesh D Desai3.   

Abstract

BACKGROUND: This study reviewed our experience with coronary artery (CA) malperfusion secondary to type A aortic dissection.
METHODS: Between 2002 and 2017, 76 patients presented with CA malperfusion, with a dissection flap limited to the aorta in the region of the coronary ostium (type A lesion) in 26 (34%), with a dissection flap involving the CA itself (type B lesion) in 32 (42%), or with complete avulsion of the CA (type C lesion) in 18 (24%).
RESULTS: Ostial repair was successfully performed in 23 type A patients (88%), in 20 type B patients (63%), and in no type C patient (0%). CA bypass grafting was performed when antegrade cardioplegia could not be applied in all 18 type C patients (100%) and in 5 type B patients (16%) because of a primary entry at the coronary ostium and in 7 patients (type A: 3 patients [12%], type B: 4 patients [13%]) with evidence of CA disease (p < 0.001). Perioperative mortality in patients with CA malperfusion was high (18 patients [24%]), but there was no difference in short-term (p = 0.153) or long-term survival (log-rank p = 0.542). Also, a landmark analysis showed equal survival of discharged patients with and without CA malperfusion (log-rank p = 0.645).
CONCLUSIONS: We recommend CA bypass grafting in patients with type C lesions or in patients with underlying CA disease for optimal delivery of cardioplegia and ostial pledgetted suture repair in patients with type A lesions or type B lesions when the administration of antegrade cardioplegia is successful.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30444990     DOI: 10.1016/j.athoracsur.2018.09.065

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Type A aortic dissection complicated by malperfusion syndrome.

Authors:  Elizabeth L Norton; Minhaj S Khaja; David M Williams; Bo Yang
Journal:  Curr Opin Cardiol       Date:  2019-11       Impact factor: 2.161

2.  Coronary artery disease in aortic aneurysm and dissection.

Authors:  Joon Chul Jung; Kay-Hyun Park
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-11-08

3.  Perioperative and Short-Term Outcomes of Sinus Replacement and Conservative Repair for Aortic Root in Acute Type A Aortic Dissection: A Prospective Cohort Study.

Authors:  Yi Chang; Xiangyang Qian; Hongwei Guo; Yizhen Wei; Cuntao Yu; Xiaogang Sun; Bo Wei; Qiong Ma; Yi Shi
Journal:  Front Cardiovasc Med       Date:  2022-05-19

4.  Short-term outcomes of acute coronary involvement in type A aortic dissection without myocardial ischemia: a multiple center retrospective cohort study.

Authors:  Ming Gong; Haiyang Li; Hongjia Zhang; Maozhou Wang; Ruixin Fan; Tianxiang Gu; Chengwei Zou; Zonggang Zhang; Zhonghong Liu; Chenhui Qiao; Lizhong Sun
Journal:  J Cardiothorac Surg       Date:  2021-04-23       Impact factor: 1.637

5.  Impact of unintentional coronary angiography on outcomes of emergency surgery in acute type A aortic dissection: a retrospective study.

Authors:  Hao Peng; Wei Liu; Kai-Tao Jian; Yu Xia; Jian-Shi Liu; Li-Zhong Sun; Yun-Qing Mei
Journal:  BMC Cardiovasc Disord       Date:  2022-08-24       Impact factor: 2.174

6.  Outcomes of surgical treatment on type A acute aortic dissection accompanied with coronary artery involvement.

Authors:  Wei Qin; Rui Fan; Jiankai Wang; Jian Li; Fuhua Huang; Xin Chen
Journal:  Front Surg       Date:  2022-09-26

7.  Coronary Malperfusion Secondary to Acute Type A Aortic Dissection: Surgical Management Based on a Modified Neri Classification.

Authors:  Guang Tong; Jinlin Wu; Zerui Chen; Donglin Zhuang; Shuang Zhao; Yaorong Liu; Yongchao Yang; Zhichao Liang; Ruixin Fan; Zhongchan Sun; Tucheng Sun
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.